Family Medicine · Boone, NC
NPI
1154567915
Since 2008
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
400 Shadowline Dr, Ste #104
Boone, NC, 28607
Phone (828) 268-1187
Groups this clinician bills Medicare through
Medicare paid, 2024
$94K
1,893 services
Medicare patients, 2024
394
Average age 75
Drug cost, 2024
$1.1M
10,563 prescriptions
Company payments, 2023
$48.54
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher McCracken was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 662 times for 365 patients. In total Christopher McCracken billed 1,893 services in 35 codes, and Medicare paid $94K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 662 | 365 | $11.54 | $7,642 |
| 99214 Office E&M - Established | Office | 506 | 306 | $80.13 | $41K |
| 36415 Venipuncture Blood Collection | Office | 259 | 186 | $8.65 | $2,240 |
| 99215 Office E&M - Established | Office | 202 | 166 | $122.56 | $25K |
| G0008 Administration of influenza virus vaccine | Office | 56 | 56 | $29.85 | $1,671 |
| 90662 Vaccine Product | Office | 50 | 50 | $80.18 | $4,009 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 25 | 25 | $124.61 | $3,115 |
| 99213 Office E&M - Established | Office | 13 | 13 | $53.74 | $699 |
By year: 2022 $80K for 1,129 services; 2023 $83K for 1,202 services; 2024 $94K for 1,893 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 259 | 186 | $8.65 | $2,240 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher McCracken prescribed most often to Medicare patients was Atorvastatin Calcium, with 665 prescriptions and refills. In total Christopher McCracken wrote 10,563 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 665 | 1,908 | 201 | $5,986 |
| Lisinopril Generic | 386 | 1,115 | 115 | $2,507 |
| Amlodipine Besylate Generic | 385 | 1,085 | 111 | $2,328 |
| Omeprazole Generic | 365 | 921 | 99 | $5,049 |
| Fluoxetine Hcl Generic | 360 | 864 | 97 | $3,191 |
| Metformin Hcl Er Metformin Hcl | 354 | 982 | 104 | $2,382 |
| Metoprolol Succinate Generic | 334 | 917 | 98 | $3,983 |
| Levothyroxine Sodium Generic | 323 | 868 | 81 | $3,393 |
| Hydrochlorothiazide Generic | 283 | 815 | 93 | $970 |
| Losartan Potassium Generic | 277 | 759 | 80 | $2,210 |
| Rosuvastatin Calcium Generic | 260 | 720 | 80 | $3,706 |
| Valsartan Generic | 225 | 613 | 67 | $5,280 |
| Tamsulosin Hcl Generic | 214 | 543 | 63 | $3,089 |
| Trazodone Hcl Generic | 185 | 467 | 62 | $1,888 |
| Fluticasone Propionate Generic | 184 | 298 | 65 | $2,819 |
Brand drugs: 1,504 claims; generic drugs: 8,986 claims; opioid claims: 66.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Christopher McCracken $48.54 ($48.54 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $48.54.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $48.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.